Acute Kidney Injury in Patients With CoVID-19

We aimed to investigate the effect of Acute Kidney Injury (AKİ) on the prognosis of patients hospitalised for COVID-19.

Completed

Looking for future studies?

Key information

Conditions

Covid19 Acute Kidney Injury COVID-19 Coronaviridae Infections Coronavirus Infections Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Infections Kidney Diseases Lung Diseases Male Urogenital Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Renal Insufficiency Respiratory Tract Diseases Respiratory Tract Infections Urogenital Diseases Urologic Diseases Virus Diseases

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Usak University

Uşak, 64100, Turkey (Türkiye)

About this study

The effect of Acute Kidney Injury (AKİ) on the prognosis of patients hospitalised for COVID-19. Patients hospitalised for COVID-19 and acute kidney injury will be enrolled. The duration of hospitalisation, mortality rates will be compared in COVID-19 patients with and without acute kidney injury.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients hospitalised with COVID-19.
Patients hospitalised with COVID-19 with Acute Kidney Injury

Exclusion criteria

Treatment and study plan

duration of hospitalization, mortality rate

Other

duration of hospitalization, mortality rates of patients hospitalised for COVID-19 evaluated and compared in patients with and without acute kidney injury.

Primary outcomes

mortality rate

Time frame: 6 months

mortality rates of COVID-19 patients with and without Acute Kidney Injury
duration of hospitalisation

Time frame: 6 months

time between admission to hospital and discharge for COVID-19 patients with and without Acute Kidney Injury

Sponsors and collaborators

Lead sponsor

Uşak University

Other

Registry information

Official study title

The Effect of Acute Kidney Injury on Prognosis in Patients Hospitalised for COVID-19.

Acronym: AKI-COVID-19

Important dates

Study start: 2020
Primary completion: 2020
Study completion: 2020
First posted: May 4, 2021
Registry last updated: May 4, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed